Table 3.
Adverse events (≥Grade 3; Common Terminology Criteria for Adverse Events. v. 3.0)
| Toxicities of treatments | Total (n = 23) | 70.4 GyE/16 Fr (n = 14) | 70.4 GyE/32 Fr (n = 9) |
|---|---|---|---|
| Acute dermatitis | |||
| > Grade 3 | 8 (35%) | 7 (50%) | 1 (11%) |
| Grade 4 | 1 (4%) | 1 (7%) | – |
| Late dermatitis | |||
| Grade 4 | 5 (22%)a | 5 (36%)a | – |
| Late myositis | |||
| Grade 3 | 2 (9%)a | 2 (14%)a | – |
| Late neuropathyb | |||
| Grade 3 | 4 (17%) | 2 (14%) | 2 (22%) |
GyE, Gy equivalents.
a
Two patients had Grade 4 dermatitis and Grade 3 myositis.
b
Neuropathy includes motor disorder, sensory disorder/pain, and urinary retention.